AtlasXomics Inc.

AtlasXomics Inc.

Biotechnology

New Haven, CT 2,310 followers

Charting the unexplored depths of spatial biology

About us

AtlasXomics, a 2020 Yale spin-out, is helping researchers understand the delicate epigenetic interplay and networks between cell types in their native environment that drives pathogenesis. We have helped over 50 investigators in oncology, aging, and neuroscience among other fields to locate and characterize driving epigenetic mechanisms in the tissue microenvironment. These mechanisms underly disease states and treatment responses. AtlasXomics combines epigenomics (spatial ATAC-seq and spatial CUT&Tag) with histology to provide insight that is often missed by bulk or single cell genomic tools. Our technology is primed for multi-omics studies in the same tissue section that uniquely positions us to identify and verify functional epigenetic mechanisms with proteome and transcriptome output. Mapping the cellular environment with an unbiased epigenome focus is needed to bring research closer to ground truth in diseased tissue to improve success rates for therapeutic interventions.

Industry
Biotechnology
Company size
11-50 employees
Headquarters
New Haven, CT
Type
Privately Held
Founded
2020

Locations

Employees at AtlasXomics Inc.

Updates

  • View organization page for AtlasXomics Inc., graphic

    2,310 followers

    View profile for Colin Ng, graphic

    Vice President at AtlasXomics

    Excited to share that AtlasXomics Inc. has been continuing to work with the team at LatchBio to simplify the complexity of spatial biology data analysis, particularly spatial epigenome and multi-omics data. We know how challenging it can be for researchers without programming experience to navigate these complex datasets, which is why we’ve developed an interactive, no-code bioinformatics suite to make it easier for biologists to explore their spatial epigenome data. James McGann and I will be presenting this toolset on October 21st at Latch’s 'Data Infrastructure for Biotech,' where we’ll discuss our vision of making spatial epigenome analysis a part of every research question. Stay tuned for more!

    • No alternative text description for this image
  • View organization page for AtlasXomics Inc., graphic

    2,310 followers

    We’re thrilled to continue working with Latch Bio to simplify spatial biology data analysis. Our bioinformatics suite makes it easy for biologists to explore complex spatial epigenome and multi-omics data. Join us on October 21st, when Colin Ng and James McGann will present this exciting toolset at Latch’s 'Data Infrastructure for Biotech,' and share our vision for making spatial epigenomics accessible to all researchers.

    View profile for Colin Ng, graphic

    Vice President at AtlasXomics

    Excited to share that AtlasXomics Inc. has been continuing to work with the team at LatchBio to simplify the complexity of spatial biology data analysis, particularly spatial epigenome and multi-omics data. We know how challenging it can be for researchers without programming experience to navigate these complex datasets, which is why we’ve developed an interactive, no-code bioinformatics suite to make it easier for biologists to explore their spatial epigenome data. James McGann and I will be presenting this toolset on October 21st at Latch’s 'Data Infrastructure for Biotech,' where we’ll discuss our vision of making spatial epigenome analysis a part of every research question. Stay tuned for more!

    • No alternative text description for this image
  • View organization page for AtlasXomics Inc., graphic

    2,310 followers

    Thank you for the kind words! Our progress at AtlasXomics Inc. wouldn’t have been possible without the support of LatchBio. Stay tuned for our chat next week, where we discuss how our improvements have impacted the field of spatial biology! 🧬 #Epigenetics #SpatialBiology

    View profile for Kyle Giffin, graphic

    Co-Founder & COO @ LatchBio

    Quick appreciation post for an inspiring team called AtlasXomics Inc. using technology to make people's lives better. I've been fortunate to work with this team for the past 2 years and am consistently inspired by how quickly they are improving, and how much they care. In essence, Atlas is a team of 27 scientists and engineers in Connecticut building a platform to reveal the underlying causes of disease. They gather tissue from scientists around the world - cancer tissue, heart tissue, brain tissue - and then create spatial maps of how disease is progressing in that tissue (based on overlaid gene expression and epigenetic signatures). The results are these beautiful and awe-inspiring spatial maps that elucidate disease progression. (It is insane to me that humans are making such rapid advancements to truly understand how diseases like cancer and cardiovascular disease develop, and collaborating to find cures.) The rate of progress is astounding too. Similar to how youtube videos went from 180p to 4k resolution in a few years, exponential change in resolution is happening here.  What you see below is the brain of a mouse at different levels of spatial resolution. Each map, as you go left to right, displays higher and higher resolution of spatial context. Giving a clearer picture into the state of the disease. From 2,500 pixels --> 9,200 pixels --> 48,400 pixels in just 12 months. We often hear about exponential improvements in technology, but now you can actually see them. I'll be talking with Colin Ng next week about their team's journey and the details of how they built this. Feel free to tune in. Link below.

    • No alternative text description for this image
    • No alternative text description for this image
  • AtlasXomics Inc. reposted this

    View organization page for LatchBio, graphic

    5,546 followers

    AtlasXomics Inc. is creating beautiful maps at cellular resolution to reveal the epigenetic underpinnings of disease development. Creating these maps generates 100s of TBs of data and requires a vast computational infrastructure. Tune in to our webinar on Thursday, August 1st to hear from Colin Ng, VP of AtlasXomics, about how they partner with LatchBio to overcome this data challenge and deliver quicker insights to their customers. Register here to join: https://lnkd.in/gMPmWATC

    • No alternative text description for this image
  • AtlasXomics Inc. reposted this

    View organization page for LatchBio, graphic

    5,546 followers

    We are thrilled to host a webinar with one of our partners, AtlasXomics Inc.! As a pioneer in spatial biology technologies, AtlasXomics offers the first and only comprehensive spatial epigenome solution at a cellular resolution. Their platform is now used by over 50 labs to uncover the epigenetic drivers behind key disease areas. Join us on Thursday, August 1st to hear from Colin Ng, VP at AtlasXOmics, as he discusses the development of their breakthrough platform and how they’ve utilized LatchBio to unlock key insights for their customers. We hope to see you there! Register here to tune in: https://lnkd.in/gMPmWATC

    • No alternative text description for this image
  • View organization page for AtlasXomics Inc., graphic

    2,310 followers

    Thank you, Mathieu Lupien, for this incredible opportunity to sponsor the 2025 Cancer Genetics and Epigenetics Gordon Research Conferences. For those in the research community, we invite you to explore the comprehensive spatial omics solutions provided by AtlasXomics Inc. We are dedicated to supporting advancements in cancer research and are proud to be part of this event! #epigenetics #genomics

    View profile for Mathieu Lupien, graphic

    Senior Scientist @UHN, founder of CoBE, Harvard U. & McGill U. alumni

    For your Spatial Omics needs in research, explore all the options provided by AtlasXomics Inc. They are key supporters of the 2025 Cancer Genetics and Epigenetics Gordon Research Conferences: https://lnkd.in/gvfBHf8v Also consider to donate using the following link to show that you are also an integral partner of the cancer research community: https://lnkd.in/gVei9AFz

    Decoding the Cancer Genome and Epigenome

    Decoding the Cancer Genome and Epigenome

    grc.org

Similar pages

Browse jobs

Funding

AtlasXomics Inc. 2 total rounds

Last Round

Series unknown

US$ 3.9M

See more info on crunchbase